Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose

Hot topics
Chairs: F. Martinez (New York, United States of America), E. Wouters (Maastricht, Netherlands)
Aims: To present and discuss the data of three recent randomised controlled trials that explored the ability of intensified inhaled corticosteroid (ICS) therapy to prevent exacerbations in patients with asthma and COPD who present with acute poor symptom control or upper respiratory tract infections (URTIs).
Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
D. Jackson (Madison, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Quadrupling the inhaled glucocorticoid dose to abort asthma exacerbations
T. Harrison (Nottingham (Nottinghamshire), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Intensified therapy with inhaled corticosteroids and long-acting b2-agonists (LABAs) at the onset of URTIs to prevent COPD exacerbations: a multicentre randomised double-blind placebo-controlled trial
D. Stolz (Basel, Switzerland)
No content made available
No content made available
LAMA/LABA vs. LABA/ICS and triple therapy – is ICS in again?
D. Lipson (Wynnewood, United States of America)
WebcastSlide presentation
WebcastSlide presentation